USPTO to grant UC foundational CRISPR patent

A notice of allowance on a core CRISPR patent application will put IP covering the most foundational aspects of the game-changing gene editing technology in the hands of two rival parties.

The Regents of the University of California, the University of Vienna and Emmanuelle Charpentier received a notice of allowance on the initial CRISPR-Cas9 patent application, U.S. Patent Application No. 13/842,859, at the center of the dispute with the Broad Institute of MIT and Harvard over ownership of the gene editing technology...